Page 4«..3456..1020..»

Category : Nanomedicine

COVID-19 Impact on Nanomedicine Market Size, Latest Trends, Growth and Share 2020 to 2026| Clinical Cardiology, Urology, Genetics, Orthopedics -…

United States of America:-The Nanomedicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Nanomedicine market size is expected to gain market growth in the forecast period of 2020 to 2026, with a CAGR of xx% in the forecast period of 2020 to 2026 and will expected to reach USD xx million by 2026, from USD xx million in 2019.

Under COVID-19 Outbreak, how the Nanomedicine Industry will develop is also analyzed in detail in COVID Impact Chapter of this report.

For Better Understanding, Download FREE Sample Copy of Nanomedicine Market Report(Including full TOC, Graphs, Sample Data, and Tables)@

Some of top players influencing the Global Nanomedicine market:

Clinical Cardiology, Urology, Genetics, Orthopedics, Ophthalmology

Note: We can provide market report in regional language too, German/French/Japanese. We have researched the situation of COVID-19 thoroughly and Our new sample has been updated to reflect COVID-19 Impact on industry trends. We also offer a 25% discount.

Market segmentation

Nanomedicine market is split by Type and by Application. For the period 2015-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Majortype, primarily split into

Pharmaceuticals and Healthcare

Major applications/end users, including

Regenerative MedicineIn-vitro & In-vivo DiagnosticsVaccinesDrug Delivery

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert(Note: Our reports include the analysis of the impact of COVID-19 on this industry. Our updated sample pages shows impact of Covid-19 on Industry trends.):

This report examines all the key factors influencing growth of global Nanomedicine market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Nanomedicine market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.

The Nanomedicine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Nanomedicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Regional analysis is another highly comprehensive part of the research and analysis study of the global Nanomedicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Nanomedicine markets. For the historical and forecast period 2015 to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nanomedicine market.

Get Table of Content, Tables, and Figures of Nanomedicine Market Report:

Some of the key questions answered in this report:

What will the market growth rate, growth momentum or acceleration market carries during the forecast period?Which are the key factors driving the Nanomedicine market?What was the size of the emerging Nanomedicine market by value in 2020?What will be the size of the emerging Nanomedicine market in 2026?Which region is expected to hold the highest market share in the Nanomedicine market?What trends, challenges and barriers will impact the development and sizing of the Global Nanomedicine market?What is sales volume, revenue, and price analysis of top manufacturers of Nanomedicine market?What are the Nanomedicine market opportunities and threats faced by the vendors in the global Nanomedicine Industry?

The reports conclusion leads into the overall scope of the Global market with respect to feasibility of investments in various segments of the market, along with a descriptive passage that outlines the feasibility of new projects that might succeed in the Global Nanomedicine market in the near future. The report will assist understand the requirements of customers, discover problem areas and possibility to get higher, and help in the basic leadership manner of any organization. It can guarantee the success of your promoting attempt, enables to reveal the clients competition empowering them to be one level ahead and restriction losses.

About Us

Market Report Expert is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports.

Contact USJames ThompsonMarket Report ExpertPhone: +1-816-301-6258Email [emailprotected]Web:-

Continued here:
COVID-19 Impact on Nanomedicine Market Size, Latest Trends, Growth and Share 2020 to 2026| Clinical Cardiology, Urology, Genetics, Orthopedics -...

Recommendation and review posted by Alexandra Lee Anderson

Healthcare Nanotechnology (Nanomedicine) Market Growth Analysis, Share, Demand by Regions, Types and Analysis of Key Players- Research Forecasts to…

The Healthcare Nanotechnology (Nanomedicine) Market was valued at US$ XX million in 2019 and is projected to reach US$ XX million by 2025, at a CAGR of XX% during the forecast period. In this study, 2019 has been considered as the base and 2020 to 2025 as the forecast period to estimate the market size for Healthcare Nanotechnology (Nanomedicine) Market

Deep analysis about Healthcare Nanotechnology (Nanomedicine) market status (2016-2019), competition pattern, advantages and disadvantages of products, industry development trends (2019-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to downstream buyers of this industry have been analysed scientifically. This report will help you to establish comprehensive overview of the Healthcare Nanotechnology (Nanomedicine) Market.

Get a Sample Copy of the Global Healthcare Nanotechnology (Nanomedicine) Market Report at:

The Healthcare Nanotechnology (Nanomedicine) Market can be split based on product types, major applications and regions.

By Disease:Cardiovascular DiseasesOncological DiseasesNeurological DiseasesOrthopedic DiseasesInfectious DiseasesOther Diseases

Key Applications:1. Drug Delivery2. Biomaterials3. Active Implants4. Diagnostic Imaging5. Tissue Regeneration6. Other

Healthcare Nanotechnology (Nanomedicine) Market Key companies covered / Analyzed in the report are:

Sanofi SACelegene CorporationCytImmune Sciences Inc.Johnson & JohnsonLuminex CorporationMerck & Co. Inc.NanobiotixPfizer Inc.Starpharma Holdings LimitedTaiwan Liposome Company Ltd

The Healthcare Nanotechnology (Nanomedicine) Market report provides analysis & data at a regional level (North America, Europe, Asia Pacific, Middle East & Africa , Rest of the world) & Country level (13 key countries The U.S, Canada, Germany, France, UK, Italy, China, Japan, India, Middle East, Africa, South America)

Inquire or share your questions, if any:

Key questions Answered in the report:1. What is the current size of the Healthcare Nanotechnology (Nanomedicine) Market, at a global, regional & country level?2. How is the market segmented, who are the key end user segments?3. What are the key drivers, challenges & trends that is likely to impact businesses in the Healthcare Nanotechnology (Nanomedicine) Market?4. What is the likely market forecast & how will be impacted Healthcare Nanotechnology (Nanomedicine) Market?5. What is the competitive landscape, who are the key players?6. What are some of the recent M&A, PE / VC deals that have happened in the Healthcare Nanotechnology (Nanomedicine) Market?

The report also analysis the impact of COVID 19 based on a scenario based modelling. This provides a clear view of how has COVID impacted the growth cycle & when is the likely recovery of the industry is expected to pre-covid levels.

Contact us:i2iResearch info to intelligenceLocational Office: *India, *United States, *GermanyEmail: [emailprotected]Toll-free: +1-800-419-8865 | Phone: +91 98801 53667

See the rest here:
Healthcare Nanotechnology (Nanomedicine) Market Growth Analysis, Share, Demand by Regions, Types and Analysis of Key Players- Research Forecasts to...

Recommendation and review posted by Alexandra Lee Anderson

Johns Hopkins Department of Otolaryngology-Head and Neck Surgery receives $15M contribution – The Hub at Johns Hopkins

ByHub staff report

Philanthropist and Johns Hopkins Medicine trustee David M. Rubenstein has made a $15 million commitment to the Department of Otolaryngology-Head and Neck Surgery at Johns Hopkins to support the department's research.

Image caption: David M. Rubenstein

The gift, his second pledge of that size to the department, will establish the David M. Rubenstein Precision Medicine Center of Excellence and will deepen his support for basic science researchers focused on the development of therapeutic approaches to preserve and restore hearing. Three strategic project teams, working in collaboration with researchers across Johns Hopkins University, will explore inner ear hair cell repair, sensory neuron repair, and nanomedicine drugs and drug delivery.

Rubenstein's gift will also support core facilities for these teams, consisting of:

Additionally, funds from this gift will support an annual conference and a speaker series.

"David's initial gift has helped Johns Hopkins researchers make important discoveries in several crucial areas related to hearing and hearing loss," said Paul B. Rothman, dean of the School of Medicine and CEO of Johns Hopkins Medicine. "But there is so much more to be done in this area, and once again, David has stepped forward. We are grateful for all that his generosity has made possible so far, and we are even more excited about what this new commitment will allow us to accomplish going forward. In the end, this work will help the millions of people who struggle every day with hearing problems."

Rubenstein's earlier gift to the department, made in 2015, funded the creation of an endowment to support cross-institutional accelerator grants. Any researcher at Johns Hopkins may apply for a grant for new or existing research to further the understanding of hearing. Grant amounts vary. In FY19, a total of $800,000 was awarded to seven different research projects, plus research core support. The earlier gift also established an endowed professorship, providing critical funds in perpetuity to support a leading faculty member in research and teaching.

"David's support has enabled innovative research projects that leverage the expertise and imagination of scientists, engineers, and clinicians from across Johns Hopkins," said Paul Fuchs, the inaugural David M. Rubenstein Research Professor of OtolaryngologyHead and Neck Surgery. "This is particularly important as we move from basic discovery of molecular and cellular mechanisms, to targeting these for therapeutic benefit. Current efforts employ gene therapy to correct inherited deafness, to regenerate cochlear hair cells, or to enhance protection from acoustic trauma. Other strategies aim to re-establish lost connections from inner ear to brain, a significant contributor to noise-induced and age-related hearing loss."

To learn more about some of the advances made possible through Rubenstein's generosity and hear from the researchers, visit the Otolaryngology-Head and Neck Surgery YouTube playlist.

Rubenstein is a founder and co-executive chairman of The Carlyle Group, a global investment firm. Rubenstein is a noted philanthropist and a long-time member of the Johns Hopkins Medicine board of trustees.

"It is a privilege to support the talented and committed researchers and doctors of Johns Hopkins who are helping people suffering from hearing loss," Rubenstein said. "I am impressed with the progress made in recent years and hope this new gift will accelerate and deepen those efforts."

See original here:
Johns Hopkins Department of Otolaryngology-Head and Neck Surgery receives $15M contribution - The Hub at Johns Hopkins

Recommendation and review posted by Alexandra Lee Anderson

Healthcare Nanotechnology (Nanomedicine) Market Competition by Companies and Countries, Industry Chain Structure, Shares, Supply, Demands,…

Healthcare Nanotechnology (Nanomedicine) Market report provides profound research of industry players, dynamics, and strategies are segmented and sub-segmented to simplify the actual conditions of the industry. The report also covers scope of product market, research methodology, Porters Five Force analysis, and Competitive landscape of industry. This report scrutinizes all the key factors influencing growth of global Healthcare Nanotechnology (Nanomedicine) market, including production and value chain analysis, pricing structure, demand-supply scenario, profit margins.

Get a Sample Copy of the Report

Top Players Are:

Key Market Trends:

The Growth of Nanomedicine is Expected to Provide High Opportunities for the Treatment of Neurological Diseases, Over the Forecast Period

A large number of brain disorders with neurological and psychological conditions result in short-term and long-term disabilities. Recent years observed a significant number of research studies being published on methods for the synthesis of nanoparticle-encapsulated drugs within in vivo and in vitro studies. The insufficient absorbance of oral drugs administered for a range of neurological conditions, such as Alzheimers disease, Parkinson disease, tumor, neuro-AIDS, among others, opens up the necessity of nanomedicine with stem cell therapy. Some of the registered nanoparticles for the complex CNS treatment are a gold nanoparticle, lipid nanoparticle, and chitosan nanoparticles.

Other than neurological diseases, research-based progress was found in the treatment of cancers, with the scientific communities identifying new metabolic pathways to find better drug combination using nanomedicine.

North America is Expected to Hold the Largest Share in the Market

In the United States, several companies are closely observing the developments in nanostructured materials across various applications in the healthcare industry, including medical devices, to improve efficiency and efficacy. In the United States, the National Nanotechnology Initiative (NNI), which was initiated in 2000, is among the supreme bodies that manage all nanotechnology-related activities. Under the NNI, several agencies are working in collaboration with companies and universities. For instance, nano-manufacturing in Small Business Innovation Research (SBIR) programs were developed for both commercial and public use. Companies are targeting the treatment of several cancer types and infectious diseases through immunotherapy, where nanoemulsion vaccines and drugs play a significant role. In the United States, one of the major challenges associated with nanotechnology is the ability to integrate nanoscale materials into new devices and systems, along with an application of novel properties at the nano-level. Thus, most of the companies are investing in R&D. Nanotechnology is likely to play a significant role in the delivery of drugs. In the recent strategic plan presented by the NNI in 2016, several programs were identified to further advance the research and development programs, over the forecast period.

For More Information or Query or Customization Before Buying, Visit at

Market Overview:

Report Highlights:

Scope of the Report:

As per the , the healthcare nanotechnology (nanomedicine) market includes products that are nanoformulations of the existing drugs or new drugs or are nanobiomaterials. The market is segmented by its application in the medical field, as drug delivery, biomaterials, active implants, diagnostic imaging, tissue regeneration, and other applications. The market is also segmented by its use in the treatment of diseases, like cardiovascular diseases, oncological diseases, neurological diseases, orthopedic diseases, infectious diseases, and other diseases.<

Competitive Landscape:

Most of the companies present in the market are efficient at the technological front, but require significant support for enhancing their services and expanding their businesses. Thus, mergers and acquisitions offer significant opportunities to gain the attention of a large number of providers across developed regions.

Purchase this Report (Price 4250 USD for single user license)

Detailed TOC of Healthcare Nanotechnology (Nanomedicine) Market Report 2024:

1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study



4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Growing Prevalence of Cancer and Genetic and Cardiovascular Diseases4.2.2 Increasing Advancements in Nanoscale Technologies for Diagnostic Procedures4.2.3 Growing Preference for Personalized Medicines4.3 Market Restraints4.3.1 High Cost4.3.2 Stringent Regulations for Commercial Introduction4.4 Porters Five Forces Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION5.1 By Application5.1.1 Drug Delivery5.1.2 Biomaterials5.1.3 Active Implants5.1.4 Diagnostic Imaging5.1.5 Tissue Regeneration5.1.6 Other Applications5.2 By Disease5.2.1 Cardiovascular Diseases5.2.2 Oncological Diseases5.2.3 Neurological Diseases5.2.4 Orthopedic Diseases5.2.5 Infectious Diseases5.2.6 Other Diseases5.3 Geography5.3.1 North America5.3.1.1 US5.3.1.2 Canada5.3.1.3 Mexico5.3.2 Europe5.3.2.1 France5.3.2.2 Germany5.3.2.3 UK5.3.2.4 Italy5.3.2.5 Spain5.3.2.6 Rest of Europe5.3.3 Asia-Pacific5.3.3.1 China5.3.3.2 Japan5.3.3.3 India5.3.3.4 Australia5.3.3.5 South Korea5.3.3.6 Rest of Asia-Pacific5.3.4 Middle East & Africa5.3.4.1 GCC5.3.4.2 South Africa5.3.4.3 Rest of Middle East & Africa5.3.5 South America5.3.5.1 Brazil5.3.5.2 Argentina5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Sanofi SA6.1.2 Celegene Corporation6.1.3 CytImmune Sciences Inc.6.1.4 Johnson & Johnson6.1.5 Luminex Corporation6.1.6 Merck & Co. Inc.6.1.7 Nanobiotix6.1.8 Pfizer Inc.6.1.9 Starpharma Holdings Limited6.1.10 Taiwan Liposome Company Ltd


Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Tea-filled Tin Market Size and Share Analysis 2021 Opportunities in Grooming Regions, Worldwide Growth Survey, Market Trends, and Company Overview with Covid-19 Impact till 2026

Developers Kits Market Size and Share Analysis 2021 Opportunities in Grooming Regions, Worldwide Growth Survey, Market Trends, and Company Overview with Covid-19 Impact till 2026

Testing, Inspection, and Certification Market Size with Share 2021 Opportunities and Future Trends, Investment Analysis, Growth Overview of Top Companies and Global Forecast Analysis till 2024

Big Data Analytics in Manufacturing Industry Market Size with Share 2021 Opportunities and Future Trends, Investment Analysis, Growth Overview of Top Companies and Global Forecast Analysis till 2024

Euro Container Market Size and Share Analysis 2021 Opportunities in Grooming Regions, Worldwide Growth Survey, Market Trends, and Company Overview with Covid-19 Impact till 2026

Particulate Filters Market Analysis with Impact of Covid-19 on Industry Size 2020 | Future Growth and Challenges by Manufacturers and Marketing Strategy Forecast to 2026 | Industry

Non Licensed Sports Merchandise Market Size and Development Trends Analysis 2021: Global Opportunities and Strategic Movement by Players, Revenue, Share and Innovations Forecast to 2026

Floor Saw Cutting Equipment Market Growth Analysis by Size 2021: Report Outline Major Key Players, Development Plans, Global Share, Business Opportunities and Drivers Forecast to 2026

L-Cysteine and Its Hydrochloride Market Size and Development Trends Analysis 2021: Global Opportunities and Strategic Movement by Players, Revenue, Share and Innovations Forecast to 2026

Cisatracurium Besylate Injection Market 2020 with Global Industry Size and Share, Future Growth Rate, Leading Players Analysis, Trending Technologies, Business Strategies Forecast to 2026

Rotor Spinning Machinery Market Size, Share Analysis 2020 Global Analysis by Key Players, Growth Overview, Type and Applications by Regions Forecast to 2025 | Industry

Home Use WiFi Router Market Revenue, Business Growth 2020: Demand and Applications, Business Statistics, Competitors Strategy, Size, Share Forecast to 2026 | Industry

See the original post:
Healthcare Nanotechnology (Nanomedicine) Market Competition by Companies and Countries, Industry Chain Structure, Shares, Supply, Demands,...

Recommendation and review posted by Alexandra Lee Anderson

Meticulous Report on Nanomedicine Market 2021-2027 | GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc.,…

To provide the global outlook of the Nanomedicine Market a new statistical study has added by HealthCare Intelligence Markets to its massive database. During the analysis of this market the existing industries, as well as upcoming start-ups, have been considered. It helps to make informed decisions in the businesses. Well explained Porters five analysis and SWOT analysis have been used by a researcher of the report. The research report is comprised market trends and holistic business information that can pinpoint market pinpoint analysis along with revenue, growth, and profit over a predictable period. This provides a complete analysis of driver, paper and market opportunities.

Ask for sample copy of this [emailprotected]

Profiling Key players: GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd.

It relates to new Nanomedicine Market competitors and recognized players. This report includes the Nanomedicine Market situation and forecasts of global and key regions, with the introduction of vendors, regions, product types and end enterprises and this report calculates product types and final industry in the world and major regions.

This market report includes analysts, managers, Nanomedicine Market industry experts, and access research that is designed to help key people view graphs and tables, as well as data that records the resources needed to conduct their own analysis. This report, which deals with information integration and research potential with results, predicted a strong rise in this market in the product section and in all regions.

Ask for a discount on this [emailprotected]

Highlights of the Report:

Lastly, this report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market.

For more information ask our experts @

If you have any special requirements, please let us know and we will offer you the report as per your requirements.

About Us:

HealthCare Intelligence Markets Reports provides market intelligence & consulting services to a global clientele spread over 145 countries. Being a B2B firm, we help businesses to meet the challenges of an ever-evolving market with unbridled confidence. We craft customized and syndicated market research reports that help market players to build game-changing strategies. Besides, we also provide upcoming trends & future market prospects in our reports pertaining to Drug development, Clinical & healthcare IT industries. Our intelligence enables our clients to make decisions with which in turn proves a game-changer for them. We constantly strive to serve our clients better by directly allowing them sessions with our research analysts so the report is at par with their expectations.

Contact Us:Address: 90, State Office Center,90, State Street Suite 700,Albany, NY 12207Email:[emailprotected]Website:www.healthcareintelligencemarkets.comPhone:+1 (888) 616-2766

See the original post:
Meticulous Report on Nanomedicine Market 2021-2027 | GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc.,...

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – LionLowdown

Nanomedicine Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

Nanomedicine Market Drivers and Restrains:Nanomedicine is an application of nanotechnology, which are used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine usages nanoscale manipulation of materials to improve medicine delivery. Therefore, nanomedicine has facilitated the treatment against various diseases. The nanomedicine market includes products that are nanoformulations of the existing drugs and new drugs or are nanobiomaterials. The research and development of new devices as well as the diagnostics will become, more effective, enabling faster response and the ability to treat new diseases are likely to boost the market growth.


The nanomedicine markets are driven by factors such as developing new technologies for drug delivery, increase acceptance of nanomedicine across varied applications, rise in government support and funding, the growing need for therapies that have fewer side effects and cost-effective. However, long approval process and risks associated with nanomedicine (environmental impacts) are hampering the market growth at the global level. An increase in the out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are likely to create lucrative opportunities in the nanomedicine market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nanomedicine Market Segmentation Analysis:Based on the application, the nanomedicine market has been segmented into cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. The oncology segment held the dominant market share in 2018 and is projected to maintain its leading position throughout the forecast period owing to the rising availability of patient information and technological advancements. However, the cardiovascular and neurology segment is projected to grow at the highest CAGR of XX% during the forecast period due to presence of opportunities such as demand for specific therapeutic nanovectors, nanostructured stents, and implants for tissue regeneration.

Nanomedicine Market Regional Analysis:Geographically, the Nanomedicine market has been segmented into North America, the Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the Nanomedicine market in 2018 due to the rising presence of patented nanomedicine products, the availability of advanced healthcare infrastructure and the rapid acceptance of nanomedicine. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period thanks to rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, the rising investments in research and development activities for the introduction of advanced therapies and drugs are predicted to accelerate the growth of this region in the near future.

Nanomedicine Market Competitive landscapeMajor Key players operating in this market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc, and Johnson & Johnson. Manufacturers in the nanomedicine are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

The objective of the report is to present a comprehensive analysis of Nanomedicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Nanomedicine Market dynamics, structure by analyzing the market segments and project the Nanomedicine Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Nanomedicine Market make the report investors guide.


Scope of the Nanomedicine Market:

Nanomedicine Market by Modality:

Diagnostics TreatmentsNanomedicine Market by Diseases:

Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases Ophthalmological Diseases Immunological DiseasesNanomedicine Market by Application:

Neurology Cardiovascular Anti-Inflammatory Anti-Infectives OncologyNanomedicine Market by Region:

Asia Pacific North America Europe Latin America Middle East AfricaNanomedicine Market Major Players:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc Johnson & Johnson Mallinckrodt plc. Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Cytimmune Sciences, Inc.


Chapter One: Nanomedicine Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanomedicine Market Competition, by Players

Chapter Four: Global Nanomedicine Market Size by Regions

Chapter Five: North America Nanomedicine Revenue by Countries

Chapter Six: Europe Nanomedicine Revenue by Countries

Chapter Seven: Asia-Pacific Nanomedicine Revenue by Countries

Chapter Eight: South America Nanomedicine Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanomedicine by Countries

Chapter Ten: Global Nanomedicine Market Segment by Type

Chapter Eleven: Global Nanomedicine Market Segment by Application

Chapter Twelve: Global Nanomedicine Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanomedicine Market Report at:

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage


Email: [emailprotected]

Contact: +919607065656/ +919607195908

Read more:
Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region - LionLowdown

Recommendation and review posted by Alexandra Lee Anderson

Resveratrol and prostate cancer: the power of phytochemicals – DocWire News

This article was originally published here

Curr Med Chem. 2020 Dec 28. doi: 10.2174/0929867328666201228124038. Online ahead of print.


Prostate cancer is the fifth cause of tumor-related deaths in man worldwide. Due to its long latency period, this pathology represents an ideal type of disease for chemopreventive studies. Among the drugs considered thus far for the treatment of prostate cancer, the natural compound resveratrol emerged as very promising. Resveratrol is a widely recognized as chemopreventive agent and was shown to potentiate the antitumor activity of conventional chemotherapeutics in several tumors, including prostate cancer. Here we overview the literature of the last five years and summarize the recent achievements of resveratrol and its derivatives as antimetastatic agents in prostate cancer. Moreover, drug combination studies as well as nanomedicine approaches proposed to improve resveratrol activity and to overcome delivery drawbacks are addressed. The last part of the review discusses the clinical trials containing resveratrol ongoing on cancer patients.

PMID:33371831 | DOI:10.2174/0929867328666201228124038

View original post here:
Resveratrol and prostate cancer: the power of phytochemicals - DocWire News

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Market Forecast Estimation & Approach 2020-2026 | GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc.,…

The Global Nanomedicine Market report provides information by Top Players, Geography, End users, Applications, Competitor analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends and Forecast.

Initially, the report provides a basic overview of the industry including definitions, classifications, applications, and industry chain structure. The Nanomedicine market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

To Get Copy of Sample Report Kindly Connect with us

2020 Global Nanomedicine Market Report is a professional and in-depth research report on the worlds major regional market conditions of the Nanomedicine industry, focusing on the main regions and the main countries (United States, Europe, Japan and China).

Global Nanomedicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer.

The Top players are

Nanomedicine Market Report based on Product Type:

Nanomedicine Market Report based on Applications:

Get Extra Discount on Nanomedicine Market Report, If your Company is Listed in Above Key Players List @

The report introduces Nanomedicine basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis. Insightful predictions for the Nanomedicine market for the coming few years have also been included in the report.

The report focuses on global major leading Nanomedicine Market players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.

The Nanomedicine industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions offered.



Chapter 1: Nanomedicine Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: Nanomedicine Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Nanomedicine.

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Nanomedicine.

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Nanomedicine by Regions (2014-2020).

Chapter 6: Nanomedicine Production, Consumption, Export and Import by Regions (2014-2020).

Chapter 7: Nanomedicine Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Nanomedicine.

Chapter 9: Nanomedicine Market Analysis and Forecast by Type and Application (2020-2026).

Chapter 10: Market Analysis and Forecast by Regions (2020-2026).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

For More Details on Impact of COVID-19 on Nanomedicine Market

About Affluence:

Affluence Market Reports is the next generation of all your research needs with a strong grapple on the worldwide market for industries, organizations, and governments. Our aim is to deliver exemplary reports that meet the definite needs of clients, which offers an adequate business technique, planning, and competitive landscape for new and existing industries that will develop your business needs.

We provide a premium in-depth statistical approach, a 360-degree market view that includes detailed segmentation, key trends, strategic recommendations, growth figures, Cost Analysis, new progress, evolving technologies, and forecasts by authentic agencies.

For more Details Contact Us:

Affluence Market Reports

Contact Person: Mr. Rohit

Phone Number: U.S +1-(424) 256-1722

Email: [emailprotected]


Read the rest here:
Nanomedicine Market Forecast Estimation & Approach 2020-2026 | GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc.,...

Recommendation and review posted by Alexandra Lee Anderson

Healthcare Nanotechnology (Nanomedicine) Market 2020: COVID19 Impact on Industry Growth, Trends, Top Manufacturer, Regional Analysis and Forecast to…

New Jersey, United States,- The in-depth research report on Healthcare Nanotechnology (Nanomedicine) Market added to its huge repository by Verified Market Research provides brilliant and comprehensive market research. The report offers an in-depth study of key market dynamics including growth drivers, restraints, and opportunities. It mainly focuses on current and historical market scenarios. It includes market competition, segmentation, geographic expansion, regional growth, market size, and other factors. The Healthcare Nanotechnology (Nanomedicine) research study is sure to benefit investors, market players and other market players. You will gain an in-depth understanding of the global market and industry.

This report focuses on Healthcare Nanotechnology (Nanomedicine) market trends, future forecast, growth opportunities, key end-user industries and market players. The aim of the study is to present the most important developments of the market in the world.

The following Manufacturers are covered in this report:

Healthcare Nanotechnology (Nanomedicine) Market Report Contains:

Market Scenario Growth, Constraints, Trends, and opportunities Segments by value and volume Status of supply and demand Competitive analysis Technological innovations Analysis of the value chain and investments

This is an up-to-date report covering the current impact of COVID-19 on the market. The coronavirus pandemic (COVID-19) has affected all aspects of life around the world. This resulted in several changes in market conditions. The rapidly changing market scenario along with the initial and future assessment of the impact is covered in the report. The report discusses all major aspects of the market with expert opinions on the current state of the market as well as historical data. This market report is a detailed study of growth, investment opportunities, market statistics, growing competitive analysis, key players, industry facts, key figures, sales, prices, revenue, gross margins, market share, business strategies, major regions, demand and developments.

The report further studies the segmentation of the market based on product types offered in the market and their end-use/applications.

Furthermore, the market research industry provides a detailed analysis of the Healthcare Nanotechnology (Nanomedicine) market for the estimated forecast period. The market research provides in-depth insights into the various market segments based on end-use, types, and geography. One of the most important characteristics of a report is the geographic segmentation of the market which includes all the key regions. This section mainly focuses on various developments in the region including the main development and how these developments will affect the market. Regional analysis provides in-depth knowledge of business opportunities, market status and forecast, possibility of generating sales, regional market by different end-users along with future types and forecast for the coming years.

Geographic Segmentation

The report offers an exhaustive assessment of different region-wise and country-wise Healthcare Nanotechnology (Nanomedicine) markets such as the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

The report includes:

Market overview Complete market analysis Analysis of the latest market developments Events of the market scenario in recent years Emerging and regional markets Segmentations up to the second and/or third level Historical, current and estimated market size in terms of value and volume Competitive analysis with an overview of the company, products, sales, and strategies. impartial market assessment Strategic recommendations to increase the presence in the business market

The study analyzes numerous factors influencing supply and demand in the Healthcare Nanotechnology (Nanomedicine) market and further assesses market dynamics that boost the market growth during the forecast period. Furthermore, the Healthcare Nanotechnology (Nanomedicine) market report offers a comprehensive analysis of the SWOT and PEST tools for all major regions such as North America, Europe, Asia Pacific, Middle East and Africa. The report offers regional expansion of the industry with product analysis, market share, and brand specifications. Furthermore, the Healthcare Nanotechnology (Nanomedicine) market research provides a comprehensive analysis of the political, economic, and technological factors which are driving the market growth in these economies.

Some Points from Table of Content

1. Study coverage2. Summary3. Healthcare Nanotechnology (Nanomedicine) Market Size by Manufacturer4. Production by region5. Consumption by region6.Healthcare Nanotechnology (Nanomedicine) Market Size by Type7. Healthcare Nanotechnology (Nanomedicine) Market size according to application8. Manufacturer profiles9. Production forecasts10. Consumption forecasts11. Analysis of customers upstream, industrial chain and downstream12. Opportunities and challenges, threats and influencing factors13. Main results14. Appendix

Verified Market Intelligence is a BI enabled database service with forecasted trends and accurate market insights on over 20,000+ tracked markets helping organizations globally with their market research needs. VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment and Key players for emerging and niche markets.

About Us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email: [emailprotected]

Read the rest here:
Healthcare Nanotechnology (Nanomedicine) Market 2020: COVID19 Impact on Industry Growth, Trends, Top Manufacturer, Regional Analysis and Forecast to...

Recommendation and review posted by Alexandra Lee Anderson

Nanobiotix Announces Closing of Underwriters’ Option to Purchase Additional ADSs – Business Wire

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:

NANOBIOTIX (Paris:NANO) (Euronext: NANO Nasdaq: NBTX the Company), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the closing of an additional 1,095,000 American Depositary Shares (ADSs) pursuant to the full exercise of the underwriters option to purchase additional ADSs in connection with the Companys initial public offering on the Nasdaq Global Select Market.

The 1,095,000 additional ADSs were sold at $13.50 per ADS, the same public offering price as in the initial public offering. Consequently, the total number of ordinary shares issued amounts to 8,395,000, including 6,540,000 in the form of ADSs, and the total net proceeds (including the sale of the additional ADSs pursuant to the exercise of the underwriters option), after deducting underwriting commissions and estimated offering expenses payable by Nanobiotix, from the initial public offering were approximately $100.4 million (82.8 million)1. The Company believes that the total net proceeds, together with its cash and cash equivalents, will be sufficient to fund its operations through the middle of the second quarter of 2023.

Nanobiotix's ordinary shares are listed on the regulated market of Euronext in Paris under the ticker symbol "NANO". Nanobiotixs ADSs began trading on the Nasdaq Global Select Market on December 11, 2020 under the ticker symbol "NBTX".

Jefferies LLC acted as global coordinator and joint book-running manager for the global offering, and Evercore Group, L.L.C. and UBS Securities LLC acted as joint book-running managers for the U.S. offering. Gilbert Dupont acted as manager for the European offering.

The initial public offering was made only by means of a prospectus. A copy of the prospectus relating to the initial public offering was filed with the U.S. Securities and Exchange Commission and may be obtained from Jefferies LLC, 520 Madison Avenue New York, NY 10022, or by telephone at 877-547-6340 or 877-821-7388, or by email at; or from Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, New York 10055, or by telephone at 888-474-0200, or by email at; or from UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, New York 10019, or by telephone at 888-827-7275, or by email at

Allocation of the Share Capital

The following table presents the expected allocation of the Company's share capital following the initial public offering, to the Companys knowledge:

Situation before the capital increase (on anon-diluted basis)

Situation after the capital increase (on a non-diluted basis and including the exercise ofthe underwriters option to purchaseadditional ADSs )


Number ofshares

% of sharecapital

% of votingrights

Number ofshares(1)

% of sharecapital

% of votingrights

Institutional Investors







Amiral Gestion







Baillie Gifford







Qatar Holding




























including Laurent Levy







Employees (







Family offices and others







Liquidity Contract












See more here:
Nanobiotix Announces Closing of Underwriters' Option to Purchase Additional ADSs - Business Wire

Recommendation and review posted by Alexandra Lee Anderson

Page 4«..3456..1020..»